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Objective: To describe a case of epithelioid trophoblastic tumor (ETT) in a postmenopausal woman,
which had several peculiar features that differentiate it from previously reported ETTs.
Case report: ETT of the uterus is a rare form of trophoblastic tumor with only 100 cases distinguished
until now. Our case differs from the previously reported ones due to its several exceptional features. Our
patient had no history of trophoblastic or gynecological disease; is postmenopausal; had endocervical
extension from the beginning; recurrences and metastasis at follow up; and had a high Ki-67 index and a
normal beta-human chorionic gonadotropin value.
Conclusion: Because precise differential diagnosis will alter the therapeutic approach and prognosis, it is
necessary for treating physicians to be aware of these unusual presentations.
Copyright © 2015, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.Introduction
Gestational trophoblastic disease (GTD) is a term used for a
group of tumors including complete and partial hydatidiformmole,
invasive mole, choriocarcinoma (CC), placental site trophoblastic
tumor (PSTT), exaggerated placental site (EPS), placental site
nodule (PSN), and epithelioid trophoblastic tumor (ETT) [1]. ETT,
the most recent addition to GTD, is an uncommon but unique
proliferative lesion whose features mimic those of squamous-cell
carcinoma (SCC) [2,3]. To date, less than 100 cases of ETT have
been reported in the literature [4,5].
The histological characteristics of ETT were ﬁrst described by
Mazur in 1989, although he used the term “atypical CC.” Later, the
term “ETT” was coined by Shih and Kurman in 1998 [2,6] for neo-
plasms composed of chorionic-type intermediate-trophoblast cells
(ITCs) [2,6e8]. This term then became widely accepted and was
eventually added to the latest 2003 World Health Organization
classiﬁcation of uterine corpus tumors [3]. In this paper, we presentitim ve Aras¸tırma Hastanesi,
vizli, Istanbul, Turkey.
).
bstetrics & Gynecology. Publisheda case of ETT, which had several peculiar features that differentiate
it from previously reported ETTs.
Case report
A 47-year-old woman (gravida 5, para 5, live 4) whose last child
was born 16 years ago and who is postmenopausal for 11 years
presented with distension and abdominal pain. She had no history
of dilatation and curettage (D&C), trophoblastic disease (TD), or
gynecological complaints. An intrauterine collection was discov-
ered and a D&C was performed. Histological examination revealed
epithelioid-type atypical cell proliferation. Subsequently, total
abdominal hysterectomy and bilateral salpingo-oophorectomy
were performed. Her uterus measured 8 cm  6 cm  5 cm and
had an irregular endometrial surface due towhitish tumoral lesions
with locally irregular borders, the largest of which measured
3.5 cm  2 cm  2 cm. The lesions were expansive, locally inﬁl-
trating the myometrium, and extending to the endometrial cavity
and endocervical canal. In hematoxylin/eosin sections, a tumor was
recognized, and was found to be composed of pleomorphic
epithelioid-like cells with a large single vesicular nucleus and
moderately or large eosinophilic or clear cytoplasm. The cells
formed nests or solid islands, and in the center of tumor nests there
was an area of hyalinization or eosinophilic debris of tumor cellby Elsevier Taiwan LLC. All rights reserved.
Figure 1. Expansive tumor inﬁltrating the myometrium. (A) The tumor is composed of
pleomorphic epithelioid-like cells with areas of hyalinization and necrosis [hematox-
ylin/eosin (HE) 100]. (B) The tumor is composed of pleomorphic epithelioid-like cells
with a large single vesicular nucleus and moderately or large eosinophilic or clear
cytoplasm (HE 400).
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trophoblast-derived tumor was the most likely diagnosis, epithe-
lial malignancies and epithelioid malignant smooth muscle tumor
(ESMT) were not ignored. The ﬁndings of immunohistochemical
(IHC) analysis are presented in Table 1 and Figure 2. Based on all the
ﬁndings, the patient was diagnosed as a case of ETT. In laboratory
examinations, beta-human chorionic gonadotropin level
(5.09 mIU/mL) and tumor markers [carcinoembryonic antigen,
1.34 ng/mL; carbohydrate antigen (CA) 125, 16.01 U/mL; CA 15-3,
25.68 U/mL; alpha-fetoprotein, 1.41 ng/mL; and CA 19-9, 0.915 U/
mL] showed no abnormality. The patient preferred to receive only
surgical therapy. During subsequent hospital visits, recurrences and
metastasis occurred (4 years and 5 years later, respectively;Table 1
Immunohistochemical features of the case.
CK CK 18 Beta-human chorionic gonadotropin Inhibin Placental alkaline ph
þ þ Focal þ Focal þ 
CK ¼ cytokeratin.Figure 3). The new lesions showed the same histopathological and
IHC characteristics of the initial tumor. The detailed clinicopatho-
logic features of the tumor are presented in Table 2.Discussion
ETT is an unusual type of trophoblastic tumor with ante-
cedent gestational events such as full-term deliveries, sponta-
neous abortions, and hydatidiform moles. The interval between
the preceding gestation and the diagnosis of ETT ranges from 1
year to 18 years (average 6.2 years) [7]. Although mostly seen in
patients between 15 years and 48 years of age (average 36.1
years) [2], it has occasionally been described in patients in the
postmenopausal age as well [9,10]. Abnormal vaginal bleeding is
the most common symptom observed in ETTs [2]. Like PSTs,
serum beta-human chorionic levels are nearly always elevated at
the time diagnosis, although the levels are generally low
(<2,500 mIU/ml) compared with those in patients with chorio-
carcinoma [2].
In literature, tumor sizes varied from 0.5 cm to 4.0 cm, the cut
surface is either solid or cystic, and focal inﬁltrative features may be
seen at the periphery [1]. The tumor cells are typically arranged in
nests, cords, and masses of cells that are intimately associated with
an eosinophilic, ﬁbrillar, hyaline-like material [1]. Neoplastic cells
are small and epithelioid with eosinophilic cytoplasm [9].
ETT has IHC expression of markers seen in normal chorionic-
type ITCs. There is diffuse expression of cytokeratin (CK) (AE1/
AE3), CK18, epithelial membrane antigen, and p63 [11]. p63 has
recently been demonstrated as a useful aid for differentiating be-
tween chorionic-type ITCs and implantation-type ITCs [11]. ETTs
are positive for inhibin-alpha, with positive cells ranging from 20%
to 80%. Human placental lactogen (hPL), human chorionic gonad-
otropin (hCG), andMel-CAM (CD146) are only focally expressed [1].
The mitotic index varies from 0 mitoses/high-power ﬁeld to 9
mitoses/high-power ﬁeld [2]. The mean Ki-67 labeling index in
ETTs is 17.7 ± 4.5% [1]. Histologic features to predict outcome are
not well established, however, some have suggested an association
between high mitotic index and more aggressive behavior [5].
ETT can occur in the uterine tissues as well as in the surrounding
or distant organs [2]. There are reports of ETT arising in the broad
ligament and fallopian tube, paracervix, parametrium, periadnexal
soft tissue, and ovary [12e14]. The morphologic and IHC features of
extrauterine ETTs are similar to those placed in the uterus [1].
For ETT, metastasis and death occur in approximately 25% and
10% of patients, respectively [2]. It is reported that ETT can metas-
tase to the lung as well as to the tissues such as brain, tonsil, and
pelvic lymph node [15].
For differential diagnosis, SCC and PSTT are the most important
cases to be kept in mind. The hyaline matrix and necrosis can
resemble keratin, and ETT can grow along the surface of the cervix,
similar to cervical SCC [5]. In differential diagnosis, almost all ETTs
are positive for inhibin-alpha and CK18, whereas SCC of the cervix
is negative for these two markers [2]. Furthermore, unlike ETT,
cervical SCC almost invariably has a very high Ki-67 labeling index
(>50%) [1]. PSTT is differentiated from ETT by its very inﬁltrative
growth pattern, prominent vascular invasion, and slightly larger
implantation site-type ITCs. PSTT are more diffusely positive for hPL
and Mel-CAM, and lack p63 expression [1]. Although seldomosphatase E-cadherin p63 Human placental lactogen Desmin and actin
þ þ  
Figure 2. Immunohistochemical features of the epithelioid trophoblastic tumor (ETT). (A) Diffuse CK18 positivity (200). (B) Nuclear p63 expression (200). (C) Diffuse E-cadherin
positivity (400). (D) Beta-human chorionic gonadotropin was focally positive in ETT (400). (E) High Ki-67 index (200). CK ¼ cytokeratin.
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The low serum b-hCG levels, benign behavior in most instances,
and the failure to respond to conventional chemotherapy are the
characteristic features of ETT [2].Figure 3. At spiral computerized tomography of the thorax, a large cavitary lesion
measuring 5.5 cm  4.4 cm  4.3 cm on the costal pleura with thin borders and
septations was found at the right lung laterobasal segment.A literature review for ETT revealed that our case has certain
inconsistent features worth mentioning. First, in contrast to most
of the previous reports, our patient was a 47-year-old post-
menopausal woman. In addition, she had no history of TD or
D&C. Admission to hospital with abdominal pain and distension
instead of presenting with a gynecological complaint was
another diversity. Furthermore, the serum b-hCG level was very
close to the normal level and it continues to be normal. In
addition, mitotic counts and Ki-67 rates were relatively high. Not
surprisingly, and in accordance with some reports that suggested
an association between high mitotic index and more aggressive
behavior [5], recurrence had occurred after the ﬁrst operation.
Unfortunately, a lung metastasis appeared at the 4th year.
Although the level of b-hCG was low, a benign behavior was not
observed.
ETT is an extremely infrequent tumor, seen mostly in the
reproductive age and is associated with GTD. The diagnosis of ETT
can usually be made on morphological grounds. However, one
should be aware that it can also be present in postmenopausal
women and without a history of GTD. Thus, accurate differential
diagnosis would properly guide therapy and change prognosis.
Table 2
Clinicopathologic features of the case.
Period Symptoms and signs Procedure Level of b-hCG
(mIU/mL)a
MC 10/high-
power ﬁeld
Ki-67 index
(%)
Histopathologic
diagnosis
May 2007 Epithelioid-type atypical cell proliferation in D&C TAH and BSO 5.09 6e7 38 ETT
July 2011 Lesion in the vagina and below the abdominal incision line Excisional biopsy 5.25 1e2 and 7e8,
respectively
50 and 50,
respectively
ETT (recurrence)
December 2011 Dyspnea; in PET/CT, a lesion in the right lung inferior
lobe laterobasal segment with a central cavern
Transthoracic
ﬁne-needle biopsy
48.98 d d Epithelioid-type
atypical cells
March 2012 Lesion in the vaginal cuff Excisional biopsy 14.26 9e10 45 ETT (recurrence)
March 2012 Lesion in the right lung Lobectomy 16.20 7e8 20 ETT (metastasis)
BSO¼ bilateral salpingo-oophorectomy; D&C¼ dilatation and curettage; ETT¼ epithelioid trophoblastic tumor;MC¼mitotic count; PET/CT¼ positron emission tomography/
computed tomography; TAH ¼ total abdominal hysterectomy; b-hCG ¼ beta-human chorionic gonadotropin.
a Normal range for b-hCG: 5e50 mIU/mL.
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